SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation
CRSP 63.99+4.7%Oct 31 9:30 AM EDT
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Ian@SI who wrote (52147)8/5/2025 3:40:40 PM
From: Art Bechhoefer  Read Replies (2) of 52153
 
It's one thing to believe tau causes Alzheimer's and another thing altogether to state that tau tangles are associated with AD. To date, there are no FDA approved drugs to clear tau, though there is at least one drug in phase 2 clinical trials that looks promising. The approved AD drugs, which treat only beta amyloid plaques, have limited success, and then only for early stage AD. I would not assume that a drug to treat tau tangles is unlikely to be successful, especially when at least one drug is already in phase 2.

Art
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News